Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine added to chemoradiotherapy in stage I-III small cell lung cancer
NL-OMON41612Phase 1Active, not recruiting
- Sponsor
- Maastro Clinic
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of chloroquine in small cell lung cancer (SCLC), sponsored by Maastro Clinic. Primary endpoint: Toxicity. Started Feb 2013; status: active, not recruiting.
02
Drugs
chloroquine
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NL-OMON41612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41612.